May 23 (Reuters) - Integra Lifesciences Holdings Corp
IART.O :
* INTEGRA LIFESCIENCES-INITIATED VOLUNTARY GLOBAL RECALL OF
ALL
PRODUCTS MADE IN BOSTON FACILITY DISTRIBUTED BETWEEN MARCH 1,
2018 AND MAY 22
* INTEGRA LIFESCIENCES - CO CONCLUDED ON MAY 22 IT EXPECTS
WILL
INCUR IMPAIRMENT CHARGE RELATED TO WRITE-OFF OF INVENTORIES,
NET, OF ABOUT $22 MILLION
* INTEGRA LIFESCIENCES HOLDINGS CORP - EXPECTS IMPAIRMENT
CHARGE
WILL BE RECORDED IN QUARTER ENDING JUNE 30, 2023
* INTEGRA LIFESCIENCES HOLDINGS CORP- FOR Q2, CO SEES
REPORTED
REVENUES IN THE RANGE OF $372 MILLION TO $376 MILLION
* INTEGRA LIFESCIENCES - SEES FY REVENUE, ADJUSTED EPS FOR
APRIL
EARNINGS WOULD BE NEGATIVELY AFFECTED BY ABOUT $60 MILLION &
$0.35, RESPECTIVELY
* INTEGRA LIFESCIENCES HOLDINGS CORP- FOR Q2, ADJUSTED. EPS
TO BE
IN THE RANGE OF $0.55 TO $0.59
Source text: [ID:http://ml6.in/ykJiU]
Further company coverage: IART.O
((Reuters.Briefs@thomsonreuters.com;))